DIAGNOSIS AND TREATMENT OF MF AND PV: Where Are We and Where Are We Going?

CME: 3.0

Upon successful completion of this activity, you should be better prepared to:

  • Determine the impact of genetics, symptom burden, and risk stratification on therapy selection in MPNs
  • Evaluate the clinical profiles of current and emerging therapeutic strategies in MPNs across lines of therapy
  • Identify and manage disease-associated symptoms and treatment-related toxicities in patients with MPNs
  • Translate updated clinical trial evidence and guidelines into personalized treatment plans for patients with MPNs to optimize care across the disease continuum

Post a comment to this article